Namibia Pharmaceuticals and Healthcare Report Q1 2014:Life Sciences Market Research Reports

Life Sciences Market Research Reports

LSAT prep from HLS-educated instructors LSATMax includes video lessons, unlimited personal attention & support, and over 6,000 real questions from previous LSAT's. Enroll for just $299. From our sponsors

Namibia Pharmaceuticals and Healthcare Report Q1 2014 Nov 20th 2013, 00:00, by vyankatesh BMI View: Increased longevity in developed markets translates into an increased demand for aged care healthcare services and medicines. However, in emerging markets such as Namibia, despite increased life expectancy, communicable diseases will remain a significant health burden over the next two decades - continuing to limit revenue earning opportunities for companies whose product portfolios contain medicines for the treatment of long-term diseases. Headline Expenditure Forecasts ? Pharmaceuticals: NAD2.15bn (US$262mn) in 2012 to NAD2.47bn (US$264mn) in 2013; +15.3% in local currency and +0.8% in US dollar terms. ? Healthcare: NAD5.30bn (US$646mn) in 2012 to NAD5.85bn (US$623mn) in 2013; +10.4% in … Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=131633. Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/namibia-pharmaceuticals-and-healthcare-report-q1-2014-market-report.html.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions